These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 2902381)
21. Neutralizing monoclonal antibody against a external envelope glycoprotein (gp110) of SIVmac251. Matsumi S; Matsushita S; Yoshimura K; Javaherian K; Takatsuki K AIDS Res Hum Retroviruses; 1995 Apr; 11(4):501-8. PubMed ID: 7632464 [TBL] [Abstract][Full Text] [Related]
22. Application of a procedure starting with an HIV-I/HIV-2 mixed EIA. Chou MJ; Chen HL; Lin HC; Lin CC Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1990 Nov; 23(4):291-301. PubMed ID: 1983137 [TBL] [Abstract][Full Text] [Related]
23. HIV-1 and HIV-2 infection associated with AIDS in Abidjan, Côte d'Ivoire. Odehouri K; De Cock KM; Krebs JW; Moreau J; Rayfield M; McCormick JB; Schochetman G; Bretton R; Bretton G; Ouattara D AIDS; 1989 Aug; 3(8):509-12. PubMed ID: 2508711 [TBL] [Abstract][Full Text] [Related]
24. Unusual serological profiles in AIDS. Marlink R; Allan J; Essex M Lancet; 1986 Jun; 1(8494):1389. PubMed ID: 2872505 [No Abstract] [Full Text] [Related]
25. Serological markers in early stages of human immunodeficiency virus infection in haemophiliacs. Allain JP; Laurian Y; Paul DA; Senn D Lancet; 1986 Nov; 2(8518):1233-6. PubMed ID: 2878129 [TBL] [Abstract][Full Text] [Related]
26. Possible beneficial effects of neutralizing antibodies and antibody-dependent, cell-mediated cytotoxicity in human immunodeficiency virus infection. Sawyer LA; Katzenstein DA; Hendry RM; Boone EJ; Vujcic LK; Williams CC; Zeger SL; Saah AJ; Rinaldo CR; Phair JP AIDS Res Hum Retroviruses; 1990 Mar; 6(3):341-56. PubMed ID: 1971182 [TBL] [Abstract][Full Text] [Related]
27. Evidence of serological cross-reactivities with human immunodeficiency virus types 1 and 2 and human T-lymphotropic virus types I and II in sera of pregnant women in Ibadan, Nigeria. Olaleye DO; Ekweozor CC; Sheng Z; Rasheed S Int J Epidemiol; 1995 Feb; 24(1):198-203. PubMed ID: 7797344 [TBL] [Abstract][Full Text] [Related]
28. Competitive enzyme-immunoassays using native viral antigens to discriminate between HIV-1 and HIV-2 infections. Baillou A; Barin F; Léonard G; Denis F; Petat E; Canas Ferreira WF; M'Boup S; Goudeau A J Virol Methods; 1990 Jul; 29(1):81-9. PubMed ID: 2211958 [TBL] [Abstract][Full Text] [Related]
29. Characterization of dual HIV-1 and HIV-2 serological profiles by polymerase chain reaction. Léonard G; Chaput A; Courgnaud V; Sangaré A; Denis F; Brechot C AIDS; 1993 Sep; 7(9):1185-9. PubMed ID: 8216974 [TBL] [Abstract][Full Text] [Related]
30. [Prevalence of anti-HIV-2 antibodies in a population at risk attending the drug-dependence center of the Rho hospital]. Albert F; Corazza M; Rotondi L; Segrè C Boll Ist Sieroter Milan; 1989; 68(2):122-6. PubMed ID: 2577476 [TBL] [Abstract][Full Text] [Related]
31. Distinction between HIV-1 and HIV-2 infection using novel synthetic lipopeptide conjugates as antigens in enzyme immunoassays. Böltz T; Hummel RP; Tröger W; Rübsamen-Waigmann H; Biesert L; Müller-Lantzsch N; Koch P; Bessler W; Jung G J Virol Methods; 1988 Dec; 22(2-3):173-82. PubMed ID: 2464607 [TBL] [Abstract][Full Text] [Related]
32. Comparative analysis of HIV-1 and HIV-2 indeterminate western blot patterns. Ayisi NK; Aidoo M West Afr J Med; 1994; 13(3):164-7. PubMed ID: 7841107 [TBL] [Abstract][Full Text] [Related]
33. Antibody response in primary human immunodeficiency virus infection. Gaines H; von Sydow M; Sönnerborg A; Albert J; Czajkowski J; Pehrson PO; Chiodi F; Moberg L; Fenyö EM; Asjö B Lancet; 1987 May; 1(8544):1249-53. PubMed ID: 2884379 [TBL] [Abstract][Full Text] [Related]
34. Carrier bound synthetic oligopeptides in ELISA test systems for distinction between HIV-1 and HIV-2 infection. Modrow S; Höflacher B; Gürtler L; Deinhardt F; Wolf H J Acquir Immune Defic Syndr (1988); 1989; 2(2):141-8. PubMed ID: 2467975 [TBL] [Abstract][Full Text] [Related]
35. Diagnosis and prevalence of HIV-2 antibodies in different population subsets in The Netherlands. van der Poel CL; Lelie PN; Reesink HW; Couroucé AM; Cot MC; Exel-Oehlers PJ; Theobalds I; Buitenwerf J; Cameron A; Huisman JG Vox Sang; 1989; 57(4):249-53. PubMed ID: 2575826 [TBL] [Abstract][Full Text] [Related]
36. Monoclonal antibodies to conserved regions of the major core protein (gag24) of HIV-1 and HIV-2. Carpio E; Duarte C; Hinkula J; Broliden PA; Rosén J; Campal A; Gavilondo J; Wahren B; Jondal M AIDS Res Hum Retroviruses; 1991 Jan; 7(1):97-101. PubMed ID: 1707645 [TBL] [Abstract][Full Text] [Related]
37. Serum reactivity to HIV-1 accessory gene products distinguishes East African from West African HIV strains as infecting agent. Goudsmit J; Dekker JT; Boucher CA; Smit L; De Ronde A; Debouck C; Barin F AIDS Res Hum Retroviruses; 1989 Oct; 5(5):475-7. PubMed ID: 2590553 [TBL] [Abstract][Full Text] [Related]
38. Isolation and antigenic characterization of human immunodeficiency virus (HIV) in Brazil. Galvão-Castro B; Ivo-Dos-Santos J; Couto-Fernandez JC; Bongertz V; Chequer-Bou-Habib D; Sion FS; Barth OM; Pereira H; Pereira MS Mem Inst Oswaldo Cruz; 1987; 82(4):453-6. PubMed ID: 3507914 [TBL] [Abstract][Full Text] [Related]
39. [Serological confirmation of HIV infections in hospital practice: analysis of indeterminate western blot results]. Bottier D; Caroff B; Goldschmidt P; Mbopi Keou FX; Cotigny S; Matta FM; Longuet MF; Bélec L Pathol Biol (Paris); 1992 Mar; 40(3):223-9. PubMed ID: 1608665 [TBL] [Abstract][Full Text] [Related]
40. Seroprevalence of HTLV-I in Portugal and evidence of double retrovirus infection of a healthy donor. Cardoso EA; Robert-Guroff M; Franchini G; Gartner S; Moura-Nunes JF; Gallo RC; Terrinha AM Int J Cancer; 1989 Feb; 43(2):195-200. PubMed ID: 2563718 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]